Discovery of best-in-class long-acting peptide drugs for clinically validated targets.
Derek Cole
Founder & CEO, Ferdia Therapeutics
Ferdia Therapeutics is a San Diego based, private biotechnology company dedicated to the discovery of long-acting peptide therapeutics suitable for once-weekly dosing in a patient friendly, multi-use pen device. Our goal is to apply half-life extension strategies to discover novel, long-acting lead peptides with excellent potency, solubility and selectivity for clinically validated therapeutic targets.